Inmunoglobulina conejo anti-linfocitos t humanos

GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION

20 mg concentrado para solución para perfusiónSpainMarketedAuthorised 20 Oct 1999

Packs

Pack	Code	Status
GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 10 viales de 5 ml	611509
GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 10 viales de 10 ml	611517
GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 5 ml	819524
GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 10 ml	819938

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Inmunoglobulina conejo anti-linfocitos t humanos

GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION

20 mg concentrado para solución para perfusiónSpainMarketedAuthorised 20 Oct 1999

Product informationAsk Osler about it

Packs

Pack	Code	Status
GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 10 viales de 5 ml	611509
GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 10 viales de 10 ml	611517
GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 5 ml	819524
GRAFALON 20 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 10 ml	819938

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entry

AEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Inmunoglobulina conejo anti-linfocitos t humanos
Strength: 20 mg
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 20 Oct 1999
Registration: 62759
Marketing authorisation holder: Neovii Biotech Gmbh
Procedure: National, MRP or DCP
Supply: Uso Hospitalario